• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:

ophthalmology

Brought to you by:
0
Close-up of human eye
Biotech

Atsena gene therapy hits safety goals, closes retinal splits

Gene therapy outfit Atsena Therapeutics has debuted data showing its eye disease candidate led to no serious treatment-related adverse events.
Darren Incorvaia May 19, 2025 12:59pm
close-up image of an eye

Beacon shines a light on positive early data from eye disease ph. 2

May 7, 2025 7:15am
eye eyeball retinal diseases

J&J gene therapy fails ph. 3 rare eye disease trial

May 5, 2025 11:33am
 Large layoffs of employees Wooden figures of people going to the exit

Opthea lays off 65% of staff after back-to-back phase 3 flops

Apr 10, 2025 7:52am
eye eyeball eye art

Opthea scraps wet AMD program after eye drug loses to Lucentis

Mar 31, 2025 6:55am
Pac man eat MA deal buy sell merger

Alcon gains majority stake in Aurion after power struggle

Mar 27, 2025 9:23am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings